Overview

Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)

Status:
Completed

Trial end date:
2007-12-01

Target enrollment:

Participant gender:

Summary

This study is testing if under the tongue olanzapine for schizophrenia, related psychosis, schizoaffective disorder or bipolar disorder will have less weight gain than olanzapine that is swallowed, in patients who are already gaining weight on olanzapine.

Phase:

Phase 4

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Olanzapine